---
title: "BORELLINI FLAVIA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/82a41b1e-3d63-5aed-95aa-2e7a8bab2829
json: https://whiteintel.dev/api/public/dossier/82a41b1e-3d63-5aed-95aa-2e7a8bab2829
identifier: sec:0001867426
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BORELLINI FLAVIA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001867426`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/82a41b1e-3d63-5aed-95aa-2e7a8bab2829  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/82a41b1e-3d63-5aed-95aa-2e7a8bab2829  

## Ownership & control

### Holdings / subsidiaries

- **Revolution Medicines, Inc.** (director) — https://whiteintel.dev/entity/69f58bea-eda5-5fda-9043-f7c5d5abebe9
- **SUNESIS PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/febc2d34-a6fa-5886-8edb-3883a966f115

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BORELLINI FLAVIA**. Human view: https://whiteintel.dev/entity/82a41b1e-3d63-5aed-95aa-2e7a8bab2829 · Structured JSON: https://whiteintel.dev/api/public/dossier/82a41b1e-3d63-5aed-95aa-2e7a8bab2829._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._